Hadassah Medical Organization
Jerusalem, Israel
NCT Number: NCT00226564
The response to opioids varies greatly among individuals. Some of these variability is accounted for by genetic factors.
The present study was designed to evaluate the possibility that genetic polymorphism in the gene encoding for mu opioid receptor may explain variability in the response to alfentanil during lithotripsy.
Looking for future studies?
Notify Me20 year and older
All sexes
Interventional
Not applicable
Jerusalem, Israel
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Hadassah Medical Organization
Other
The Effect of mu Opioid Receptor Polymorphism on the Response to Alfentanil During Lithotripsy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07457983
Calculi, Female Urogenital Diseases
Adıyaman, Turkey (Türkiye)
View Trial DetailsNCT07715643
Calcium Oxalate Kidney Stones, Female Urogenital Diseases
Lahore, Pakistan
View Trial DetailsNCT02214836
Calculi, Female Urogenital Diseases
Seattle, Washington, United States
View Trial DetailsNCT07377461
Calculi, Female Urogenital Diseases
Ashkelon, Israel
View Trial Details